These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 14724435)

  • 1. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
    Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
    Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation blockade improves pancreatic islet function.
    Yang Z; Chen M; Carter JD; Ellett JD; Smith KM; Nadler JL
    Transplant Proc; 2004 Nov; 36(9):2864-5. PubMed ID: 15621169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory blockade improves human pancreatic islet function and viability.
    Yang Z; Chen M; Ellett JD; Carter JD; Brayman KL; Nadler JL
    Am J Transplant; 2005 Mar; 5(3):475-83. PubMed ID: 15707401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice.
    Chou FC; Sytwu HK
    J Biomed Sci; 2009 Aug; 16(1):71. PubMed ID: 19671194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
    Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
    Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism.
    Chen M; Yang Z; Wu R; Nadler JL
    Endocrinology; 2002 Jun; 143(6):2341-8. PubMed ID: 12021199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice.
    Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Nadler JL
    Pancreas; 2003 May; 26(4):e99-104. PubMed ID: 12717280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
    Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
    Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
    Gysemans C; Stoffels K; Giulietti A; Overbergh L; Waer M; Lannoo M; Feige U; Mathieu C
    Diabetologia; 2003 Aug; 46(8):1115-23. PubMed ID: 12879250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
    Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
    Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisofylline: a potential lead for the treatment of diabetes.
    Yang Z; Chen M; Nadler JL
    Biochem Pharmacol; 2005 Jan; 69(1):1-5. PubMed ID: 15588708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
    Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
    Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10.
    Faust A; Rothe H; Schade U; Lampeter E; Kolb H
    Transplantation; 1996 Sep; 62(5):648-52. PubMed ID: 8830831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.